Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 3 (2006), Issue 12 (December)

1. Influence of sub-syndromal symptoms after remission from manic or mixed episodes.
   Br J Psychiatry, 189: 515-9. [Abstract] [Full-text]
2. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
   Neurosci Lett, 411(2): 123-7. [Abstract] [Full-text]
3. Successful use of electroconvulsive therapy in 2 cases of persistent sexual arousal syndrome and bipolar disorder.
   J ECT, 22(4): 274-5. [Abstract] [Full-text]
4. Toward a definition of a cyclothymic behavioral endophenotype: which traits tap the familial diathesis for bipolar II disorder?
   J Affect Disord, 96(3): 233-7. [Abstract] [Full-text]
5. The mood-instability hypothesis in the origin of mood-congruent versus mood-incongruent psychotic distinction in mania: validation in a French National Study of 1090 patients.
   J Affect Disord, 96(3): 215-23. [Abstract] [Full-text]
6. Validating the soft bipolar spectrum in the French National EPIDEP Study: The prominence of BP-II 1/2.
   J Affect Disord, 96(3): 207-13. [Abstract] [Full-text]
7. Dose-response relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality.
   J Affect Disord, 96(3): 249-58. [Abstract] [Full-text]
8. Endogenous and exogenous cyclicity and temperament in bipolar disorder: Review, new data and hypotheses.
   J Affect Disord, 96(3): 165-75. [Abstract] [Full-text]
9. What is familial about familial bipolar disorder? Resemblance among relatives across a broad spectrum of phenotypic characteristics.
   Arch Gen Psychiatry, 63(12): 1368-76. [Abstract] [Full-text]
10. The psychometric discriminative properties of the Peters et al Delusions Inventory: a receiver operating characteristic curve analysis.
    Compr Psychiatry, 48(1): 62-9. [Abstract] [Full-text]
11. Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders.
    Expert Rev Neurother, 6(11): 1609-27. [Abstract] [Full-text]
12. Special issue on circular insanity and beyond: Historic contributions of French psychiatry to contemporary concepts and research on bipolar disorder.
    J Affect Disord, 96(3): 141-3. [Abstract] [Full-text]
13. A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients.
    Eur Psychiatry, 21(8): 539-543. [Abstract] [Full-text]
14. Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.
    J Psychiatr Res, 41(3): 214-21. [Abstract] [Full-text]
15. Bipolar I patients with and without a history of psychotic symptoms: do they differ in their cognitive functioning?
    J Psychiatr Res, 41(3): 265-72. [Abstract] [Full-text]
16. Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report.
    Biol Psychiatry, 60(12): 1378-81. [Abstract] [Full-text]
17. Characterization of the transient receptor potential channels mediating lysophosphatidic acid-stimulated calcium mobilization in B lymphoblasts.
    Life Sci, 80(2): 89-97. [Abstract] [Full-text]
18. Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study.
    J Psychiatr Res, 41(3): 360-9. [Abstract] [Full-text]
19. The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder.
    J Psychiatr Res, 41(3): 255-64. [Abstract] [Full-text]
20. Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.
    Brain Res, 1127(1): 108-18. [Abstract] [Full-text]
21. Empirical evidence for the use of lithium and anticonvulsants in children with psychiatric disorders.
    Harv Rev Psychiatry, 14(6): 285-304. [Abstract] [Full-text]
22. What's New? The Clinical Epidemiology of Bipolar I Disorder.
    Harv Rev Psychiatry, 14(6): 273-84. [Abstract] [Full-text]
23. Inositol monophosphatase regulates localization of synaptic components and behavior in the mature nervous system of C. elegans.
    Genes Dev, 20(23): 3296-310. [Abstract] [Full-text]
24. STUDY OF DOPAMINE RECEPTORS GENES POLYMORPHISMS IN BIPOLAR PATIENTS WITH COMORBID ALCOHOL ABUSE.
    Alcohol Alcohol. [Abstract] [Full-text]
25. A relative resistance of T cells to dexamethasone in bipolar disorder.
    Bipolar Disord, 8(6): 740-50. [Abstract] [Full-text]
26. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
    Bipolar Disord, 8(6): 721-39. [Abstract] [Full-text]
27. Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children.
    Bipolar Disord, 8(6): 710-20. [Abstract] [Full-text]
28. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials.
    Bipolar Disord, 8(6): 696-709. [Abstract] [Full-text]
29. Comorbidity of eating disorders with bipolar disorder and treatment implications.
    Bipolar Disord, 8(6): 686-95. [Abstract] [Full-text]
30. Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations.
    Bipolar Disord, 8(6): 677-85. [Abstract] [Full-text]
31. Anxiety disorders and bipolar disorder: a review.
    Bipolar Disord, 8(6): 665-76. [Abstract] [Full-text]
32. Panic comorbidity with bipolar disorder: what is the manic-panic connection?
    Bipolar Disord, 8(6): 648-64. [Abstract] [Full-text]
33. A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life.
    Int Clin Psychopharmacol, 22(1): 29-37. [Abstract] [Full-text]
34. A study of the neural correlates of episodic memory and HPA axis status in drug-free depressed patients and healthy controls.
    J Psychiatr Res, 41(3): 295-304. [Abstract] [Full-text]
35. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
    Ann Pharmacother, 40(12): 2260-4. [Abstract] [Full-text]
36. Bipolar disorder: improving diagnosis and optimizing integrated care.
    J Clin Psychol, 63(1): 73-92. [Abstract] [Full-text]
37. Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics.
    Neuropsychopharmacology, 32(1): 95-102. [Abstract] [Full-text]
38. The FEZ1 gene shows no association to schizophrenia in Caucasian or African American populations.
    Neuropsychopharmacology, 32(1): 190-6. [Abstract] [Full-text]
39. Polymorphisms in the neuronal isoform of tryptophan hydroxylase 2 are associated with bipolar disorder in French Canadian pedigrees.
    Psychiatr Genet, 17(1): 17-22. [Abstract] [Full-text]
40. Adjunctive olanzapine treatment in bipolar adolescents responding insufficiently to mood stabilizers : Four case reports.
    Eur Child Adolesc Psychiatry, 15(8): 500-3. [Abstract] [Full-text]
41. Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population.
    Mol Psychiatry, 12(1): 94-104. [Abstract] [Full-text]
42. Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26.
    Mol Psychiatry, 12(1): 87-93. [Abstract] [Full-text]
43. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism.
    Mol Psychiatry, 12(1): 36-46. [Abstract] [Full-text]
44. Childhood separation anxiety and the risk of subsequent psychopathology: Results from a community study.
    Psychother Psychosom, 76(1): 47-56. [Abstract] [Full-text]
45. Race/ethnicity, substance abuse, and mental illness among suicide victims in 13 US states: 2004 data from the National Violent Death Reporting System.
    Inj Prev, 12: ii22-ii27. [Abstract] [Full-text]
46. The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia.
    Schizophr Res, 89(1): 173-6. [Abstract] [Full-text]
47. Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
    Schizophr Res, 89(1): 91-100. [Abstract] [Full-text]
48. Family functioning in bipolar I disorder.
    J Fam Psychol, 20(4): 701-4. [Abstract] [Full-text]
49. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review.
    Am J Epidemiol, 165(1): 1-13. [Abstract] [Full-text]
50. Statistical genetics concepts and approaches in schizophrenia and related neuropsychiatric research.
    Schizophr Bull, 33(1): 95-104. [Abstract] [Full-text]
51. Feeling and time: the phenomenology of mood disorders, depressive realism, and existential psychotherapy.
    Schizophr Bull, 33(1): 122-30. [Abstract] [Full-text]
52. What symptoms predict the diagnosis of mania in persons with severe/profound intellectual disability in clinical practice?
    J Intellect Disabil Res, 51: 25-31. [Abstract] [Full-text]
53. Role of aripiprazole in treating mood disorders.
    Expert Rev Neurother, 6(12): 1777-83. [Abstract] [Full-text]
54. Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study.
    Addict Behav, 32(2): 410-5. [Abstract] [Full-text]
55. Adaptation and validation of the Portuguese version of the Lithium Knowledge Test (LKT) of bipolar patients treated with lithium: cross-over study.
    Clin Pract Epidemol Ment Health, 2: 34. [Abstract] [Full-text]
56. Suicidal behaviour during different phases of bipolar disorder.
    J Affect Disord, 97(1): 101-7. [Abstract] [Full-text]
57. Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study.
    J Affect Disord, 97(1): 109-22. [Abstract] [Full-text]
58. Clinical characteristics of bipolar disorder in very young children.
    J Affect Disord, 97(1): 51-9. [Abstract] [Full-text]
59. Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder.
    J Affect Disord, 97(1): 91-9. [Abstract] [Full-text]
60. Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(1): 275-82. [Abstract] [Full-text]
61. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(1): 283-5. [Abstract] [Full-text]
62. Vernier threshold and the parallel visual pathways in bipolar disorder: a follow-up study.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(1): 86-91. [Abstract] [Full-text]
63. Behavioral activation, inhibition and mood symptoms in early-onset bipolar disorder.
    J Affect Disord, 97(1): 71-6. [Abstract] [Full-text]
64. Seasonal variations in bipolar disorder admissions and the association with climate: a population-based study.
    J Affect Disord, 97(1): 61-9. [Abstract] [Full-text]
65. Effects of calmodulin and protein kinase C modulators on transient Ca2+ increase and capacitative Ca2+ entry in human platelets: relevant to pathophysiology of bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(1): 136-41. [Abstract] [Full-text]
66. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(1): 217-24. [Abstract] [Full-text]
67. Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder.
    Neurochem Res, 32(1): 107-13. [Abstract] [Full-text]
68. Mild serotonin syndrome associated with concurrent linezolid and fluoxetine.
    Am J Health Syst Pharm, 64(1): 59-62. [Abstract] [Full-text]
69. Spectrum of effectiveness of valproate in neuropsychiatry.
    Expert Rev Neurother, 7(1): 9-16. [Abstract] [Full-text]
70. Further evidence of MAO-A gene variants associated with bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 144(1): 37-40. [Abstract] [Full-text]
71. Evidence of linkage to psychosis on chromosome 5q33-34 in pedigrees ascertained for bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 144(1): 74-8. [Abstract] [Full-text]
72. Association of the human kainate receptor GluR7 gene (GRIK3) with recurrent major depressive disorder.
    Am J Med Genet B Neuropsychiatr Genet, 144(1): 20-6. [Abstract] [Full-text]
73. Historical review of carbamazepine for the treatment of bipolar disorder.
    Pharmacotherapy, 27(1): 68-88. [Abstract] [Full-text]
74. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
    Pharmacotherapy, 27(1): 27-35. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.